X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

New report shows 200 medicines in development for heart disease and stroke

By Andrew Powaleny  |    February 20, 2018
Cardiovascular disease, which includes heart disease and stroke, is the leading cause of death in the United States, accounting for one out of every three deaths. According to the American Heart...   Read More

Copay coupons can help ease patients’ out-of-pocket costs

By Holly Campbell  |    February 16, 2018
Each year, middlemen, like pharmacy benefit managers (PBMs) and insurers, shift more of the costs of health care to patients. Ensuring patients have affordable access to their medicines is the top...   Read More

Oregon’s HB 4005 fails to deliver savings for patients

By Caitlin Carroll  |    February 14, 2018
Medicine costs are growing at the slowest rate in years, but it doesn’t feel that way to patients who are facing higher out-of-pocket costs for their health care across the board. Proposals like...   Read More

Guest Post: Driving towards a healthy heart

By Guest Contributor  |    February 8, 2018
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

340B Spotlight: Hospital system adds voice to comments about flawed 340B program

By Nicole Longo  |    February 2, 2018
Each week, more and more groups are calling attention to the 340B program and its myriad problems. Here’s a quick recap of some of the latest voices out there.   Read More

Record number of personalized medicines approved in 2017

By Emma Van Hook  |    February 1, 2018
We are in an exciting time in biomedical innovation, as rapid scientific and technological advances are leading to new ways of preventing, diagnosing, and treating disease. Nothing illustrates the...   Read More

Guest post: Help celebrate #ChampionsofScience: Nominate a pioneering researcher for the 2018 Dr. Paul Janssen Award for Biomedical Research

By Guest Contributor  |    January 29, 2018
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today’s challenges and opportunities. The Catalyst welcomes guest...   Read More

Innovation comes in many forms, including new and expanded uses of existing medicines

By Emma Van Hook  |    January 29, 2018
2017 was a record-breaking year for new drug approvals, with the U.S. Food and Drug Administration (FDA) approving 56 new drugs and biologics. But the innovation did not stop there. As the FDA...   Read More

Fact Check Friday: The truth about the cost of 340B to patients

By Nicole Longo  |    January 26, 2018
The 340B program was designed to increase access to medicines for vulnerable or uninsured patients through safety-net facilities, but all signs point to 340B doing the opposite – distorting the...   Read More

Ask About Adherence: Private-sector collaboration can lead to savings and care improvement

By Carolyn Ha  |    January 25, 2018
Ask About Adherence is a blog series featuring Q&A’s with experts and new medication adherence resources. In this post, we feature a recent study on medication non-adherence and discuss how a safe...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates